EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Drug Insight: role of the androgen receptor in the development and progression of prostate cancer

Mary-Ellen Taplin

Nature Clinical Practice Oncology · 2007-04 · 4 (4) · 236-244

DOI: 10.1038/ncponc0765 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nature Clinical Practice Oncology, 2007-04. Verfasst von Mary-Ellen Taplin. Beteiligte Einrichtung: Harvard Medical School, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA. mtaplin@partne…. Die Arbeit wurde bisher 165-mal zitiert (Crossref) und nennt 84 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Androgen AntagonistsDisease ProgressionDrug Resistance, NeoplasmHumansMaleProstatic NeoplasmsReceptors, AndrogenSignal Transduction

Substanzen

Androgen AntagonistsReceptors, Androgen

Autor:innen und Institutionen

  • Harvard Medical School, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA. mtaplin@partners.org

Zitieren

APA

Taplin, M. E. (2007). Drug Insight: role of the androgen receptor in the development and progression of prostate cancer. Nature Clinical Practice Oncology, 4(4), 236-244. https://doi.org/10.1038/ncponc0765

Vancouver

Taplin ME. Drug Insight: role of the androgen receptor in the development and progression of prostate cancer. Nature Clinical Practice Oncology. 2007;4(4):236-244. doi:10.1038/ncponc0765

BibTeX
@article{Taplin2007,
  author = {Taplin, Mary-Ellen},
  title = {Drug Insight: role of the androgen receptor in the development and progression of prostate cancer},
  journal = {Nature Clinical Practice Oncology},
  year = {2007},
  volume = {4},
  number = {4},
  pages = {236--244},
  doi = {10.1038/ncponc0765}
}
Kostenlos starten →